TRON Group, Inc. (TGRP)
0.06
-0.01
(-11.76%)
USD |
OTCM |
Feb 20, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 10.44M |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 8.89% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | |
| PS Ratio | -- |
| Price to Book Value | -- |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | -- |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 99.96% |
Profile
| TRON Group, Inc. is a clinical-stage specialty pharmaceutical company, which engages in the development of oral, topical, and injectable products for cancer, central nervous system disorders, diabetes, and infectious diseases. The company was founded on October 20, 2015 and is headquartered in Alachua, FL. |
| URL | N/A |
| Investor Relations URL | N/A |
| HQ State/Province | Florida |
| Sector | |
| Industry | |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Profile
| TRON Group, Inc. is a clinical-stage specialty pharmaceutical company, which engages in the development of oral, topical, and injectable products for cancer, central nervous system disorders, diabetes, and infectious diseases. The company was founded on October 20, 2015 and is headquartered in Alachua, FL. |
| URL | N/A |
| Investor Relations URL | N/A |
| HQ State/Province | Florida |
| Sector | |
| Industry | |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |